Immunologic Effects of Omalizumab in Children with Severe Refractory Atopic Dermatitis: A Randomized, Placebo-Controlled Clinical Trial

Publisher： Karger

E-ISSN： 1423-0097|162|1|89-93

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.162, Iss.1, 2013-06, pp. : 89-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 406-414

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e168-e168

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Efficacy and Safety of a Chinese Herbal Product (Xiao-Feng-San) for the Treatment of Refractory Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial

By  

International Archives of Allergy and Immunology, Vol. 155, Iss. 2, 2010-12 ,pp. : 141-148

Karger

Access to resources Recommend Favorite

Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China

By  

PEDIATRIC DERMATOLOGY, Vol. 35, Iss. 1, 2018-01 ,pp. : 70-75

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and microbiological effects of levofloxacin in the treatment of chronic periodontitis: a randomized, placebo‐controlled clinical trial

By  

JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (ELECTRONIC), Vol. 6, Iss. 3, 2015-08 ,pp. : 170-178

John Wiley & Sons Inc

Access to resources Recommend Favorite